A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)

• Status: Completed
• Trial end date: 2002-10-04
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to see how well simvastatin raises HDL levels in patients with Type 2 Diabetes.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Oxymetazoline; Simvastatin

Criteria

Inclusion Criteria:

• Patient has stable Type 2 diabetes mellitus at Visit 1.

• Patient meets screening criteria based on Visit 1 lab tests

Exclusion Criteria:

• Patient is pregnant, breastfeeding, or at risk of becoming pregnant

• Patient has heart disease, uncontrolled high blood pressure, or other significant disease

• Patient is taking prohibited medication(s) and is unable to stop taking them for the duration of the study